Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

John Kempen, Ph.D., M.D.

Title
Institution
Department
Address

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. UG1EY030420 (KEMPEN, JOHN H) Sep 30, 2019 - Jun 30, 2024
    NIH/NEI
    Fluorometholone as Adjunctive Therapy for Trachomatous Trichiasis Surgery
    Role: Principal Investigator
  2. R21EY026717 (KEMPEN, JOHN H) Apr 1, 2017 - Mar 31, 2019
    NIH/NEI
    Incidence of remission and of cataract in ocular inflammatory diseases
    Role: Principal Investigator
  3. R01FD003910 (KEMPEN, JOHN H) Aug 15, 2011 - Jul 31, 2014
    FDA
    Phase 1 Iontophoretic Delivery of Dexamethasone for Tx of Anterior Scleritis
    Role: Principal Investigator
  4. R56EY014943 (KEMPEN, JOHN H) May 1, 2004 - Sep 29, 2010
    NIH/NEI
    Complications of Immunosupression for Eye Diseases
    Role: Principal Investigator
  5. R01EY014943 (KEMPEN, JOHN H) May 1, 2004 - Sep 29, 2009
    NIH/NEI
    Complications of Immunosuppression for Eye Diseases
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Sobrin L, Yu Y, Susarla G, Chan W, Xia T, Kempen JH, Hubbard RA, VanderBeek BL. Risk of Non-infectious Uveitis with Female Hormonal Therapy in a Large Healthcare Claims Database. Ophthalmology. 2020 Apr 27. PMID: 32353382.
    Citations:    
  2. Agrawal R, Testi I, Mahajan S, Yuen YS, Agarwal A, Rousselot A, Raje D, Gunasekeran DV, Kon OM, Barisani-Asenbauer T, Kempen JH, Gupta A, Jabs DA, Smith JR, Bodaghi B, Zierhut M, DeSmet M, Cluskey PM, Agarwal M, Agarwal M, Aggarwal K, Agrawal M, Al-Dhibi H, Androudi S, Asyari F, Balasundaram MB, Murthy KB, Baglivo E, Banker A, Bansal R, Basu S, Behera D, Biswas J, Carreño E, Caspers L, Chee SP, Chhabra R, Cimino L, Del Rio LEC, Cunningham ET, Curi ALL, Das D, Denisova E, Denniston AK, Errera MH, Fonollosa A, George A, Goldstein DA, Crosier YG, Gurbaxani A, Invernizzi A, Isa HM, Md Islam S, Jones N, Katoch D, Khairallah M, Khosla A, Kramer M, Kumar A, Kumar A, Nora RD, Lee R, Lowder C, Luthra S, Mahendradas P, Makhoul D, Mazumdar S, Mehta S, Miserocchi E, Mochizuki M, Mohamed OS, Muccioli C, Munk MR, Murthy S, Narain S, Nascimento H, Neri P, Nguyen M, Okada AA, Ozdal P, Palestine A, Pichi F, Rathinam SR, Schlaen A, Sehgal S, Sen HN, Sharma A, Sharma K, Shoughy SS, Singh N, Singh R, Soheilian M, Sridharan S, Thorne JE, Tappeiner C, Teoh S, Tognon MS, Tugal-Tutkun I, Tyagi M, Uy H, Santos DVV, Valentincic NV, Westcott M, Yanai R, Alvarez BY, Zahedur R, Nguyen QD, Pavesio C, Gupta V. The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings. Ocul Immunol Inflamm. 2020 Apr 06; 1-11. PMID: 32250731.
    Citations:    
  3. Naidoo K, Kempen JH, Gichuhi S, Braithwaite T, Casson RJ, Cicinelli MV, Das A, Flaxman SR, Jonas JB, Keeffe JE, Leasher J, Limburg H, Pesudovs K, Resnikoff S, Silvester AJ, Tahhan N, Taylor HR, Wong TY, Bourne RRA. Prevalence and causes of vision loss in sub-Saharan Africa in 2015: magnitude, temporal trends and projections. Br J Ophthalmol. 2020 Mar 30. PMID: 32229517.
    Citations:    
  4. Agrawal R, Testi I, Mahajan S, Yuen YS, Agarwal A, Kon OM, Barisani-Asenbauer T, Kempen JH, Gupta A, Jabs DA, Smith JR, Nguyen QD, Pavesio C, Gupta V. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 1: Guidelines for Initiating Antitubercular Therapy in Tubercular Choroiditis. Ophthalmology. 2020 Jan 11. PMID: 32115264.
    Citations:    
  5. Pistilli M, Joffe MM, Gangaputra SS, Pujari SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Begum H, Fitzgerald TD, Dreger KA, Altaweel MM, Holbrook JT, Kempen JH. Visual Acuity Outcome over Time in Non-Infectious Uveitis. Ocul Immunol Inflamm. 2019 Dec 10; 1-8. PMID: 31821051.
    Citations:    
  6. Agrawal R, Agarwal A, Jabs DA, Kee A, Testi I, Mahajan S, McCluskey PJ, Gupta A, Palestine A, Denniston A, Banker A, Invernizzi A, Fonollosa A, Sharma A, Kumar A, Curi A, Okada A, Schlaen A, Heiligenhaus A, Kumar A, Gurbaxani A, Bodaghi B, Islam Shah B, Lowder C, Tappeiner C, Muccioli C, Vasconcelos-Santos DV, Goldstein D, Behra D, Das D, Makhoul D, Baglivo E, Denisova E, Miserocchi E, Carreno E, Asyari F, Pichi F, Sen HN, Uy H, Nascimento H, Tugal-Tutkun I, Arevalo JF, Davis J, Thorne J, Hisae Yamamoto J, Smith J, Garweg JG, Biswas J, Babu K, Aggarwal K, Cimino L, Kuffova L, Agarwal M, Zierhut M, Agarwal M, De Smet M, Tognon MS, Errera MH, Munk M, Westcott M, Soheilian M, Accorinti M, Khairallah M, Nguyen M, Kon OM, Mahendradas P, Yang P, Neri P, Ozdal P, Amer R, Lee R, Distia Nora R, Chhabra R, Belfort R, Mehta S, Shoughy S, Luthra S, Mohamed SO, Chee SP, Basu S, Teoh S, Ganesh S, Barisani-Asenbauer T, Guex-Crosier Y, Ozyazgan Y, Akova Y, Habot-Wilner Z, Kempen J, Nguyen QD, Pavesio C, Gupta V. Standardization of Nomenclature for Ocular Tuberculosis - Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop. Ocul Immunol Inflamm. 2019 Dec 10; 1-11. PMID: 31821096.
    Citations:    
  7. Sobrin L, Pistilli M, Dreger K, Kothari S, Khachatryan N, Artornsombudh P, Pujari SS, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Kempen JH. Factors Predictive of Remission of Chronic Anterior Uveitis. Ophthalmology. 2019 Nov 28. PMID: 31932091.
    Citations:    
  8. Testi I, Agrawal R, Mahajan S, Agarwal A, Gunasekeran DV, Raje D, Aggarwal K, Murthy SI, Westcott M, Chee SP, McCluskey P, Ho SL, Teoh S, Cimino L, Biswas J, Narain S, Agarwal M, Mahendradas P, Khairallah M, Jones N, Tugal-Tutkun I, Babu K, Basu S, Carreño E, Lee R, Al-Dhibi H, Bodaghi B, Invernizzi A, Goldstein DA, Herbort CP, Barisani-Asenbauer T, González-López JJ, Androudi S, Bansal R, Moharana B, Esposti SD, Tasiopoulou A, Nadarajah S, Agarwal M, Abraham S, Vala R, Singh R, Sharma A, Sharma K, Zierhut M, Rousselot A, Grant R, Kon OM, Cunningham ET, Kempen J, Nguyen QD, Pavesio C, Gupta V. Tubercular Uveitis: Nuggets from Collaborative Ocular Tuberculosis Study (COTS)-1. Ocul Immunol Inflamm. 2019 Nov 25; 1-9. PMID: 31763952.
    Citations:    
  9. Ung L, Acharya NR, Agarwal T, Alfonso EC, Bagga B, Bispo PJ, Burton MJ, Dart JK, Doan T, Fleiszig SM, Garg P, Gilmore MS, Gritz DC, Hazlett LD, Iovieno A, Jhanji V, Kempen JH, Lee CS, Lietman TM, Margolis TP, McLeod SD, Mehta JS, Miller D, Pearlman E, Prajna L, Prajna NV, Seitzman GD, Shanbhag SS, Sharma N, Sharma S, Srinivasan M, Stapleton F, Tan DT, Tandon R, Taylor HR, Tu EY, Tuli SS, Vajpayee RB, Van Gelder RN, Watson SL, Zegans ME, Chodosh J. Infectious corneal ulceration: a proposal for neglected tropical disease status. Bull World Health Organ. 2019 Dec 01; 97(12):854-856. PMID: 31819296.
    Citations:    
  10. Cheng CY, Wang N, Wong TY, Congdon N, He M, Wang YX, Braithwaite T, Casson RJ, Cicinelli MV, Das A, Flaxman SR, Jonas JB, Keeffe JE, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Resnikoff S, Silvester AJ, Tahhan N, Taylor HR, Bourne RRA. Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections. Br J Ophthalmol. 2020 May; 104(5):616-622. PMID: 31462416.
    Citations:    
  11. Tolesa K, Abateneh A, Kempen JH, Gelaw Y. Patterns of Uveitis among Patients Attending Jimma University Department of Ophthalmology, Jimma, Ethiopia. Ocul Immunol Inflamm. 2019 Aug 20; 1-7. PMID: 31429610.
    Citations:    
  12. Gangaputra SS, Newcomb CW, Joffe MM, Dreger K, Begum H, Artornsombudh P, Pujari SS, Daniel E, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Kempen JH. Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases. Am J Ophthalmol. 2019 12; 208:68-75. PMID: 31344346.
    Citations:    
  13. Kempen JH, Pistilli M, Begum H, Fitzgerald TD, Liesegang TL, Payal A, Zebardast N, Bhatt NP, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE. Remission Of Non-Infectious Anterior Scleritis: Incidence And Predictive Factors. Am J Ophthalmol. 2019 Apr 02. PMID: 30951689.
    Citations:    
  14. Borkar DS, Sobrin L, Hubbard RA, Kempen JH, VanderBeek BL. Techniques for improving ophthalmic studies performed on administrative databases. Ophthalmic Epidemiol. 2019 06; 26(3):147-149. PMID: 30521404.
    Citations:    Fields:    
  15. Nangia V, Jonas JB, George R, Lingam V, Ellwein L, Cicinelli MV, Das A, Flaxman SR, Keeffe JE, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Resnikoff S, Silvester AJ, Tahhan N, Taylor HR, Wong TY, Bourne RRA. Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia. Br J Ophthalmol. 2019 07; 103(7):871-877. PMID: 30409914.
    Citations:    
  16. Thorne JE, Sugar EA, Holbrook JT, Burke AE, Altaweel MM, Vitale AT, Acharya NR, Kempen JH, Jabs DA. Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial. Ophthalmology. 2019 02; 126(2):283-295. PMID: 30269924.
    Citations:    Fields:    
  17. Kempen JH, Tekle-Haimanot R, Hunduma L, Alemayehu M, Pistilli M, Abashawl A, Lawrence SD, Alemayehu W. Fluorometholone 0.1% as Ancillary Therapy for Trachomatous Trichiasis Surgery: Randomized Clinical Trial. Am J Ophthalmol. 2019 01; 197:145-155. PMID: 30267699.
    Citations:    Fields:    
  18. Kahloun R, Khairallah M, Resnikoff S, Cicinelli MV, Flaxman SR, Das A, Jonas JB, Keeffe JE, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Silvester AJ, Tahhan N, Taylor HR, Wong TY, Bourne RRA. Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections. Br J Ophthalmol. 2019 07; 103(7):863-870. PMID: 30209082.
    Citations:    
  19. Keeffe JE, Casson RJ, Pesudovs K, Taylor HR, Cicinelli MV, Das A, Flaxman SR, Jonas JB, Kempen JH, Leasher J, Limburg H, Naidoo K, Silvester AJ, Stevens GA, Tahhan N, Wong TY, Resnikoff S, Bourne RRA. Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections. Br J Ophthalmol. 2019 07; 103(7):878-884. PMID: 30209084.
    Citations:    
  20. Agrawal R, Gunasekeran DV, Agarwal A, Carreño E, Aggarwal K, Gupta B, Raje D, Murthy SI, Westcott M, Chee SP, McCluskey P, Ling HS, Teoh S, Cimino L, Biswas J, Narain S, Agarwal M, Mahendradas P, Khairallah M, Jones N, Tugal-Tutkun I, Babu K, Basu S, Lee R, Al-Dhibi H, Bodaghi B, Invernizzi A, Goldstein DA, Herbort CP, Barisani-Asenbauer T, González-López JJ, Androudi S, Bansal R, Moharana B, Mahajan S, Esposti S, Tasiopoulou A, Nadarajah S, Agarwal M, Abraham S, Vala R, Lord J, Singh R, Sharma A, Sharma K, Zierhut M, Kon OM, Kempen J, Cunningham ET, Rousselot A, Nguyen QD, Pavesio C, Gupta V. The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Description of the Spectrum of Choroidal Involvement in 245 Patients with Tubercular Uveitis. Ocul Immunol Inflamm. 2018 Aug 29; 1-11. PMID: 30156979.
    Citations:    Fields:    
  21. Mora N, Kempen JH, Sobrin L. Diabetic Retinopathy in Hispanics: A Perspective on Disease Burden. Am J Ophthalmol. 2018 12; 196:xviii-xxiv. PMID: 30138600.
    Citations:    Fields:    
  22. Sobrin L, Stanwyck LK, Pan W, Hubbard RA, Kempen JH, VanderBeek BL. Association of Hypovitaminosis D With Increased Risk of Uveitis in a Large Health Care Claims Database. JAMA Ophthalmol. 2018 05 01; 136(5):548-552. PMID: 29621365.
    Citations:    Fields:    
  23. O'Neil EC, Huang J, Suhler EB, Dunn JP, Perez VL, Gritz DC, McWilliams K, Peskin E, Ying GS, Bunya VY, Maguire MG, Kempen JH. Iontophoretic delivery of dexamethasone phosphate for non-infectious, non-necrotising anterior scleritis, dose-finding clinical trial. Br J Ophthalmol. 2018 08; 102(8):1011-1013. PMID: 29666122.
    Citations:    Fields:    
  24. Bourne RRA, Jonas JB, Bron AM, Cicinelli MV, Das A, Flaxman SR, Friedman DS, Keeffe JE, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Peto T, Saadine J, Silvester AJ, Tahhan N, Taylor HR, Varma R, Wong TY, Resnikoff S. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections. Br J Ophthalmol. 2018 05; 102(5):575-585. PMID: 29545417.
    Citations:    
  25. Sheppard JD, Foster CS, Toyos MM, Markwardt K, Da Vanzo R, Flynn TE, Kempen JH. Difluprednate 0.05% versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: Pooled Efficacy Analysis of Two Phase 3 Studies. Ocul Immunol Inflamm. 2019; 27(3):484-496. PMID: 29260952.
    Citations:    Fields:    
  26. Durrani K, Kempen JH, Foster CS. Authors Reply to Letter to the Editor- In Response to: Comment on Durrani et al.'s "Adalimumab for Ocular Inflammation". Ocul Immunol Inflamm. 2019; 27(1):71. PMID: 29043914.
    Citations:    Fields:    
  27. Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Silvester A, Stevens GA, Tahhan N, Wong TY, Taylor HR. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017 12; 5(12):e1221-e1234. PMID: 29032195.
    Citations:    
  28. Bourne RRA, Flaxman SR, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Resnikoff S, Silvester A, Stevens GA, Tahhan N, Wong TY, Taylor HR. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017 09; 5(9):e888-e897. PMID: 28779882.
    Citations: 32     Fields:    Translation:Humans
  29. Kheirkhah A, Kempen J, Dana R. Reply. Am J Ophthalmol. 2017 10; 182:202-203. PMID: 28778570.
    Citations:    Fields:    
  30. Kempen JH, Altaweel MM, Holbrook JT, Sugar EA, Thorne JE, Jabs DA. Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis. JAMA. 2017 May 16; 317(19):1993-2005. PMID: 28477440.
    Citations: 4     Fields:    Translation:Humans
  31. Daniel E, Pistilli M, Kothari S, Khachatryan N, Kaçmaz RO, Gangaputra SS, Sen HN, Suhler EB, Thorne JE, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Bhatt NP, Kempen JH. Risk of Ocular Hypertension in Adults with Noninfectious Uveitis. Ophthalmology. 2017 08; 124(8):1196-1208. PMID: 28433444.
    Citations: 1     Fields:    Translation:Humans
  32. Altaweel MM, Gangaputra SS, Thorne JE, Dunn JP, Elner SG, Jaffe GJ, Kim RY, Rao PK, Reed SB, Kempen JH. Morphological assessment of the retina in uveitis. J Ophthalmic Inflamm Infect. 2016 Dec; 6(1):33. PMID: 27613274.
    Citations: 1     
  33. Durrani K, Kempen JH, Ying GS, Kacmaz RO, Artornsombudh P, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Foster CS. Adalimumab for Ocular Inflammation. Ocul Immunol Inflamm. 2017 Jun; 25(3):405-412. PMID: 27003323.
    Citations: 4     Fields:    Translation:Humans
  34. Kempen JH, Gewaily DY, Newcomb CW, Liesegang TL, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Foster CS, Jabs DA, Payal A, Fitzgerald TD. Remission of Intermediate Uveitis: Incidence and Predictive Factors. Am J Ophthalmol. 2016 Apr; 164:110-7.e2. PMID: 26772874.
    Citations: 2     Fields:    Translation:Humans
  35. Patel AK, Newcomb CW, Liesegang TL, Pujari SS, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Artornsombudh P, Kothari S, Kempen JH. Risk of Retinal Neovascularization in Cases of Uveitis. Ophthalmology. 2016 Mar; 123(3):646-54. PMID: 26686964.
    Citations: 5     Fields:    Translation:Humans
  36. Li J, Orlin SE, Revere KE, Kempen JH. Acute onset anterior uveitis after darbepoetin alfa infusion. J Ophthalmic Inflamm Infect. 2015 Dec; 5(1):31. PMID: 26502332.
    Citations:    
  37. Sen HN, Abreu FM, Louis TA, Sugar EA, Altaweel MM, Elner SG, Holbrook JT, Jabs DA, Kim RY, Kempen JH. Cataract Surgery Outcomes in Uveitis: The Multicenter Uveitis Steroid Treatment Trial. Ophthalmology. 2016 Jan; 123(1):183-90. PMID: 26499920.
    Citations: 1     Fields:    Translation:Humans
  38. Kempen JH, Van Natta ML, Altaweel MM, Dunn JP, Jabs DA, Lightman SL, Thorne JE, Holbrook JT. Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. Am J Ophthalmol. 2015 Dec; 160(6):1133-1141.e9. PMID: 26386159.
    Citations: 5     Fields:    Translation:Humans
  39. Tomkins-Netzer O, Lightman S, Drye L, Kempen J, Holland GN, Rao NA, Stawell RJ, Vitale A, Jabs DA. Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results. Ophthalmology. 2015 Nov; 122(11):2351-9. PMID: 26359188.
    Citations: 3     Fields:    Translation:Humans
  40. Kempen JH, Altaweel MM, Drye LT, Holbrook JT, Jabs DA, Sugar EA, Thorne JE. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. Ophthalmology. 2015 Oct; 122(10):1967-75. PMID: 26298715.
    Citations: 8     Fields:    Translation:Humans
  41. Cunningham ET, Acharya N, Kempen JH, Zierhut M. Design and Interpretation of Clinic-Based Studies in Uveitis. Ocul Immunol Inflamm. 2015 Aug; 23(4):267-270. PMID: 29265967.
    Citations:    Fields:    
  42. Kothari S, Foster CS, Pistilli M, Liesegang TL, Daniel E, Sen HN, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Lawrence SD, Kempen JH. The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious Uveitis. Ophthalmology. 2015 Oct; 122(10):1987-2001. PMID: 26233626.
    Citations: 3     Fields:    Translation:Humans
  43. Ganesh SK, Bala A, Biswas J, Ahmed AS, Kempen JH. Pattern of Pediatric Uveitis Seen at a Tertiary Referral Center from India. Ocul Immunol Inflamm. 2016 Aug; 24(4):402-9. PMID: 26171572.
    Citations: 2     Fields:    Translation:Humans
  44. Subburaman GB, Hariharan L, Ravilla TD, Ravilla RD, Kempen JH. Demand for Tertiary Eye Care Services in Developing Countries. Am J Ophthalmol. 2015 Oct; 160(4):619-27.e1. PMID: 26095262.
    Citations:    Fields:    Translation:Humans
  45. Lerman MA, Lewen MD, Kempen JH, Mills MD. Uveitis Reactivation in Children Treated With Tumor Necrosis Factor Alpha Inhibitors. Am J Ophthalmol. 2015 Jul; 160(1):193-200.e1. PMID: 25892124.
    Citations: 6     Fields:    Translation:Humans
  46. Khachatryan N, Kempen JH. Immunosuppressive therapy and cancer risk in ocular inflammation patients: fresh evidence and more questions. Ophthalmology. 2015 Feb; 122(2):219-21. PMID: 25618424.
    Citations: 2     Fields:    Translation:Humans
  47. McGuire JL, Kempen JH, Localio R, Ellenberg JH, Douglas SD. Immune markers predictive of neuropsychiatric symptoms in HIV-infected youth. Clin Vaccine Immunol. 2015 Jan; 22(1):27-36. PMID: 25355798.
    Citations: 3     Fields:    Translation:HumansCells
  48. Kempen JH, Sugar EA, Varma R, Dunn JP, Heinemann MH, Jabs DA, Lyon AT, Lewis RA. Risk of cataract among subjects with acquired immune deficiency syndrome free of ocular opportunistic infections. Ophthalmology. 2014 Dec; 121(12):2317-24. PMID: 25109932.
    Citations:    Fields:    Translation:Humans
  49. Choe CH, McArthur GA, Caro I, Kempen JH, Amaravadi RK. Ocular toxicity in BRAF mutant cutaneous melanoma patients treated with vemurafenib. Am J Ophthalmol. 2014 Oct; 158(4):831-837.e2. PMID: 25036880.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  50. Sen HN, Vitale S, Gangaputra SS, Nussenblatt RB, Liesegang TL, Levy-Clarke GA, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Kempen JH. Periocular corticosteroid injections in uveitis: effects and complications. Ophthalmology. 2014 Nov; 121(11):2275-86. PMID: 25017415.
    Citations: 10     Fields:    Translation:Humans
  51. Mehta S, Linton MM, Kempen JH. Outcomes of cataract surgery in patients with uveitis: a systematic review and meta-analysis. Am J Ophthalmol. 2014 Oct; 158(4):676-692.e7. PMID: 24983790.
    Citations: 10     Fields:    Translation:Humans
  52. Sugar EA, Holbrook JT, Kempen JH, Burke AE, Drye LT, Thorne JE, Louis TA, Jabs DA, Altaweel MM, Frick KD. Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis. Ophthalmology. 2014 Oct; 121(10):1855-62. PMID: 24908205.
    Citations: 5     Fields:    Translation:Humans
  53. Sheppard JD, Toyos MM, Kempen JH, Kaur P, Foster CS. Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study. Invest Ophthalmol Vis Sci. 2014 May 06; 55(5):2993-3002. PMID: 24677110.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  54. Eftekhari K, Ghodasra DH, Haynes K, Chen J, Kempen JH, VanderBeek BL. Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study. Pharmacoepidemiol Drug Saf. 2014 Jul; 23(7):745-52. PMID: 24757075.
    Citations: 4     Fields:    Translation:Humans
  55. Hornbeak DM, Payal A, Pistilli M, Biswas J, Ganesh SK, Gupta V, Rathinam SR, Davis JL, Kempen JH. Interobserver agreement in clinical grading of vitreous haze using alternative grading scales. Ophthalmology. 2014 Aug; 121(8):1643-8. PMID: 24697913.
    Citations: 5     Fields:    Translation:Humans
  56. Artornsombudh P, Pistilli M, Foster CS, Pujari SS, Gangaputra SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH. Factors predictive of remission of new-onset anterior uveitis. Ophthalmology. 2014 Mar; 121(3):778-84. PMID: 24342020.
    Citations: 1     Fields:    Translation:Humans
  57. Levin MH, Pistilli M, Daniel E, Gangaputra SS, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Kempen JH. Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema. Ophthalmology. 2014 Feb; 121(2):588-95.e1. PMID: 24332536.
    Citations: 6     Fields:    Translation:Humans
  58. Hsieh J, Honda AF, Suárez-Fariñas M, Samson CM, Kedhar S, Mauro J, Francis J, Badamo J, Diaz VA, Kempen JH, Latkany PA. Fundus image diagnostic agreement in uveitis utilizing free and open source software. Can J Ophthalmol. 2013 Aug; 48(4):227-34. PMID: 23931458.
    Citations: 2     Fields:    Translation:Humans
  59. Joffe MM, Pistilli M, Kempen JH. Marginal structural models for comparing alternative treatment strategies in ophthalmology using observational data. Ophthalmic Epidemiol. 2013 Aug; 20(4):197-200. PMID: 23819465.
    Citations: 1     Fields:    Translation:Humans
  60. Lerman MA, Burnham JM, Chang PY, Daniel E, Foster CS, Hennessy S, Jabs DA, Joffe MM, Kaçmaz RO, Levy-Clarke GA, Mills MD, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH. Response of pediatric uveitis to tumor necrosis factor-a inhibitors. J Rheumatol. 2013 Aug; 40(8):1394-403. PMID: 23818712.
    Citations: 13     Fields:    Translation:Humans
  61. Baxter SL, Pistilli M, Pujari SS, Liesegang TL, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Kempen JH. Risk of choroidal neovascularization among the uveitides. Am J Ophthalmol. 2013 Sep; 156(3):468-477.e2. PMID: 23795984.
    Citations: 11     Fields:    Translation:Humans
  62. Kempen JH, Sugar EA, Jaffe GJ, Acharya NR, Dunn JP, Elner SG, Lightman SL, Thorne JE, Vitale AT, Altaweel MM. Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema. Ophthalmology. 2013 Sep; 120(9):1852-9. PMID: 23706700.
    Citations: 12     Fields:    Translation:Humans
  63. Friedman DS, Holbrook JT, Ansari H, Alexander J, Burke A, Reed SB, Katz J, Thorne JE, Lightman SL, Kempen JH. Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial. Ophthalmology. 2013 Aug; 120(8):1571-9. PMID: 23601801.
    Citations: 19     Fields:    Translation:Humans
  64. Mehta S, Hariharan L, Ho AC, Kempen JH. Peripapillary choroidal neovascularization in pars planitis. J Ophthalmic Inflamm Infect. 2013 Jan 15; 3(1):13. PMID: 23514324.
    Citations: 3     
  65. Domalpally A, Altaweel MM, Kempen JH, Myers D, Davis JL, Foster CS, Latkany P, Srivastava SK, Stawell RJ, Holbrook JT. Optical coherence tomography evaluation in the Multicenter Uveitis Steroid Treatment (MUST) trial. Ocul Immunol Inflamm. 2012 Dec; 20(6):443-7. PMID: 23163490.
    Citations: 6     Fields:    Translation:Humans
  66. Gregory AC, Kempen JH, Daniel E, Kaçmaz RO, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE. Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology. 2013 Jan; 120(1):186-92. PMID: 23062650.
    Citations: 24     Fields:    Translation:Humans
  67. Khairallah M, Accorinti M, Muccioli C, Kahloun R, Kempen JH. Epidemiology of Behçet disease. Ocul Immunol Inflamm. 2012 Oct; 20(5):324-35. PMID: 23030353.
    Citations: 14     Fields:    Translation:Humans
  68. Kempen JH, Sugar EA, Lyon AT, Lewis RA, Jabs DA, Heinemann MH, Dunn JP. Risk of cataract in persons with cytomegalovirus retinitis and the acquired immune deficiency syndrome. Ophthalmology. 2012 Nov; 119(11):2343-50. PMID: 22853972.
    Citations: 1     Fields:    Translation:Humans
  69. Daniel E, Pistilli M, Pujari SS, Kaçmaz RO, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Kempen JH. Risk of hypotony in noninfectious uveitis. Ophthalmology. 2012 Nov; 119(11):2377-85. PMID: 22796306.
    Citations: 8     Fields:    Translation:Humans
  70. Taylor SR, Lightman SL, Sugar EA, Jaffe GJ, Freeman WR, Altaweel MM, Kozak I, Holbrook JT, Jabs DA, Kempen JH. The impact of macular edema on visual function in intermediate, posterior, and panuveitis. Ocul Immunol Inflamm. 2012 Jun; 20(3):171-81. PMID: 22530874.
    Citations: 12     Fields:    Translation:Humans
  71. Udoetuk JD, Dai Y, Ying GS, Daniel E, Gangaputra S, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Kempen JH. Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases. Ophthalmology. 2012 Aug; 119(8):1569-74. PMID: 22484116.
    Citations: 4     Fields:    Translation:Humans
  72. Charkoudian LD, Ying GS, Pujari SS, Gangaputra S, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Kempen JH. High-dose intravenous corticosteroids for ocular inflammatory diseases. Ocul Immunol Inflamm. 2012 Apr; 20(2):91-9. PMID: 22409561.
    Citations: 4     Fields:    Translation:Humans
  73. Frick KD, Drye LT, Kempen JH, Dunn JP, Holland GN, Latkany P, Rao NA, Sen HN, Sugar EA, Thorne JE, Wang RC, Holbrook JT. Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial. Invest Ophthalmol Vis Sci. 2012 Mar; 53(3):1169-76. PMID: 22247489.
    Citations: 15     Fields:    Translation:Humans
  74. Holbrook JT, Kempen JH, Prusakowski NA, Altaweel MM, Jabs DA. Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial--lessons for comparative effectiveness trials. Clin Trials. 2011 Dec; 8(6):736-43. PMID: 21994128.
    Citations: 3     Fields:    Translation:Humans
  75. Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Louis TA, Sugar EA, Thorne JE. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology. 2011 Oct; 118(10):1916-26. PMID: 21840602.
    Citations: 65     Fields:    Translation:Humans
  76. Gangaputra SS, Altaweel MM, Peng Q, Friedman DS, Rao PK, Foster CS, Kim RY, Reed SB, Srivastava SK, Wong IG, Kempen JH. Morphologic assessment for glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) trial. Ocul Immunol Inflamm. 2011 Aug; 19(4):267-74. PMID: 21770805.
    Citations: 1     Fields:    Translation:Humans
  77. Grunwald L, Newcomb CW, Daniel E, Kaçmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH. Risk of relapse in primary acute anterior uveitis. Ophthalmology. 2011 Oct; 118(10):1911-5. PMID: 21680024.
    Citations: 1     Fields:    Translation:Humans
  78. Taju S, Tilahun Y, Ayalew M, Fikrie N, Schneider J, Kempen JH. Diagnosis and treatment of microsporidial keratoconjunctivitis: literature review and case series. J Ophthalmic Inflamm Infect. 2011 Sep; 1(3):105-10. PMID: 21559864.
    Citations: 2     
  79. Wang D, Singh K, Weinreb R, Kempen J, He M, Lin S. Central corneal thickness and related factors in an elderly American Chinese population. Clin Exp Ophthalmol. 2011 Jul; 39(5):412-20. PMID: 21105973.
    Citations:    Fields:    Translation:Humans
  80. Kempen JH. Appropriate use and reporting of uncontrolled case series in the medical literature. Am J Ophthalmol. 2011 Jan; 151(1):7-10.e1. PMID: 21163373.
    Citations: 8     Fields:    Translation:Humans
  81. Rathinam SR, Krishnadas R, Ramakrishnan R, Thulasiraj RD, Tielsch JM, Katz J, Robin AL, Kempen JH. Population-based prevalence of uveitis in Southern India. Br J Ophthalmol. 2011 Apr; 95(4):463-7. PMID: 20693551.
    Citations: 6     Fields:    Translation:Humans
  82. Galor A, Feuer W, Kempen JH, Kaçmaz RO, Liesegang TL, Suhler EB, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Thorne JE. Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol. 2010 Jul; 94(7):848-53. PMID: 20606023.
    Citations:    
  83. Ansari H, Kempen JH. Proof of concept for combined insertion of fluocinolone acetonide and glaucoma drainage implants for eyes with uveitis and glaucoma. Am J Ophthalmol. 2010 May; 149(5):699-700. PMID: 20399922.
    Citations: 1     Fields:    Translation:Humans
  84. Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Sugar EA. The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol. 2010 Apr; 149(4):550-561.e10. PMID: 20097325.
    Citations: 49     Fields:    Translation:Humans
  85. Kaçmaz RO, Kempen JH, Newcomb C, Daniel E, Gangaputra S, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Foster CS. Cyclosporine for ocular inflammatory diseases. Ophthalmology. 2010 Mar; 117(3):576-84. PMID: 20031223.
    Citations: 58     Fields:    Translation:Humans
  86. Otiti-Sengeri J, Colebunders R, Kempen JH, Ronald A, Sande M, Katabira E. The prevalence and causes of visual loss among HIV-infected individuals in Uganda. J Acquir Immune Defic Syndr. 2010 Jan; 53(1):95-101. PMID: 19927007.
    Citations: 4     Fields:    Translation:Humans
  87. Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. 2010 Mar; 149(3):423-32.e1-2. PMID: 20042178.
    Citations: 44     Fields:    Translation:Humans
  88. Zaidi AA, Ying GS, Daniel E, Gangaputra S, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Kempen JH. Hypopyon in patients with uveitis. Ophthalmology. 2010 Feb; 117(2):366-72. PMID: 20006905.
    Citations: 7     Fields:    Translation:Humans
  89. Pujari SS, Kempen JH, Newcomb CW, Gangaputra S, Daniel E, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Foster CS. Cyclophosphamide for ocular inflammatory diseases. Ophthalmology. 2010 Feb; 117(2):356-65. PMID: 19969366.
    Citations: 25     Fields:    Translation:Humans
  90. Gangaputra S, Newcomb CW, Liesegang TL, Kaçmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH. Methotrexate for ocular inflammatory diseases. Ophthalmology. 2009 Nov; 116(11):2188-98.e1. PMID: 19748676.
    Citations: 58     Fields:    Translation:Humans
  91. Spencer C, Frick K, Gower EW, Kempen JH, Wolff JL. Disparities in access to medical care for individuals with vision impairment. Ophthalmic Epidemiol. 2009 Sep-Oct; 16(5):281-8. PMID: 19874107.
    Citations:    
  92. Kempen JH, Daniel E, Dunn JP, Foster CS, Gangaputra S, Hanish A, Helzlsouer KJ, Jabs DA, Kaçmaz RO, Levy-Clarke GA, Liesegang TL, Newcomb CW, Nussenblatt RB, Pujari SS, Rosenbaum JT, Suhler EB, Thorne JE. Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ. 2009 Jul 03; 339:b2480. PMID: 19578087.
    Citations: 35     Fields:    Translation:Humans
  93. Pasadhika S, Kempen JH, Newcomb CW, Liesegang TL, Pujari SS, Rosenbaum JT, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Suhler EB. Azathioprine for ocular inflammatory diseases. Am J Ophthalmol. 2009 Oct; 148(4):500-509.e2. PMID: 19570522.
    Citations: 44     Fields:    Translation:Humans
  94. Lim LL, Scarborough JD, Thorne JE, Graham E, Kempen JH, Mackensen F, Nguyen QD, Prabriputaloong T, Read RW, Suhler EB, Schwartz JM, Smith JR. Uveitis in patients with autoimmune hepatitis. Am J Ophthalmol. 2009 Feb; 147(2):332-338.e1. PMID: 19166713.
    Citations: 2     Fields:    Translation:Humans
  95. Kempen JH. Medical management of human immunodeficiency virus infection. Indian J Ophthalmol. 2008 Sep-Oct; 56(5):385-90. PMID: 18711266.
    Citations: 2     Fields:    Translation:Humans
  96. Kaçmaz RO, Kempen JH, Newcomb C, Gangaputra S, Daniel E, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Foster CS. Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol. 2008 Dec; 146(6):828-36. PMID: 18708181.
    Citations: 21     Fields:    Translation:Humans
  97. Kempen JH, Ganesh SK, Sangwan VS, Rathinam SR. Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis. Am J Ophthalmol. 2008 Dec; 146(6):813-8.e1. PMID: 18687418.
    Citations: 25     Fields:    Translation:Humans
  98. Leung IY, Lai S, Ren S, Kempen J, Klein R, Tso MO, Lai HC. Early retinal vascular abnormalities in African-American cocaine users. Am J Ophthalmol. 2008 Oct; 146(4):612-619. PMID: 18662808.
    Citations: 1     Fields:    Translation:Humans
  99. Kempen JH, Gangaputra S, Daniel E, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Helzlsouer KJ. Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol. 2008 Dec; 146(6):802-12.e1. PMID: 18579112.
    Citations: 33     Fields:    Translation:Humans
  100. Kempen JH, Daniel E, Gangaputra S, Dreger K, Jabs DA, Kaçmaz RO, Pujari SS, Anzaar F, Foster CS, Helzlsouer KJ, Levy-Clarke GA, Nussenblatt RB, Liesegang T, Rosenbaum JT, Suhler EB. Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol. 2008 Jan-Feb; 15(1):47-55. PMID: 18300089.
    Citations: 34     Fields:    Translation:Humans
  101. Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology. 2007 Apr; 114(4):780-6. PMID: 17258320.
    Citations: 49     Fields:    Translation:HumansCells
  102. Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. Ophthalmology. 2007 Apr; 114(4):787-93. PMID: 17210182.
    Citations: 27     Fields:    Translation:HumansCells
  103. Thorne JE, Holbrook JT, Jabs DA, Kempen JH, Nichols C, Meinert CL. Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS. Ophthalmology. 2007 Mar; 114(3):591-8. PMID: 17123624.
    Citations: 8     Fields:    Translation:Humans
  104. Daniel E, Gangaputra S, Kempen JH, Jabs DA. Recurrent nodular scleritis preceding an adult TINU syndrome. Ocul Immunol Inflamm. 2006 Aug; 14(4):239-40. PMID: 16911986.
    Citations:    Fields:    Translation:Humans
  105. Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 2006 Aug; 113(8):1441-5. PMID: 16781775.
    Citations: 16     Fields:    Translation:Humans
  106. Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 2006 Aug; 113(8):1432-40. PMID: 16766032.
    Citations: 22     Fields:    Translation:Humans
  107. Daniel E, Ffytche TJ, Kempen JH, Rao PS, Diener-West M, Courtright P. Incidence of ocular complications in patients with multibacillary leprosy after completion of a 2 year course of multidrug therapy. Br J Ophthalmol. 2006 Aug; 90(8):949-54. PMID: 16707521.
    Citations:    
  108. Daniel E, Ffytche TJ, Sundar Rao PS, Kempen JH, Diener-West M, Courtright P. Incidence of ocular morbidity among multibacillary leprosy patients during a 2 year course of multidrug therapy. Br J Ophthalmol. 2006 May; 90(5):568-73. PMID: 16622085.
    Citations:    
  109. Kempen JH, Min YI, Freeman WR, Holland GN, Friedberg DN, Dieterich DT, Jabs DA. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology. 2006 Apr; 113(4):684-94. PMID: 16581429.
    Citations: 27     Fields:    Translation:HumansCells
  110. Semba RD, Martin BK, Kempen JH, Thorne JE, Wu AW. The impact of anemia on energy and physical functioning in individuals with AIDS. Arch Intern Med. 2005 Oct 24; 165(19):2229-36. PMID: 16246988.
    Citations: 18     Fields:    Translation:HumansCells
  111. Bykhovskaya I, Thorne JE, Kempen JH, Dunn JP, Jabs DA. Vogt-Koyanagi-Harada disease: clinical outcomes. Am J Ophthalmol. 2005 Oct; 140(4):674-8. PMID: 16226518.
    Citations: 19     Fields:    Translation:Humans
  112. Dunn JP, Yamashita A, Kempen JH, Jabs DA. Retinal vascular occlusion in patients infected with human immunodeficiency virus. Retina. 2005 Sep; 25(6):759-66. PMID: 16141865.
    Citations: 7     Fields:    Translation:Humans
  113. Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology. 2005 Aug; 112(8):1472-7. PMID: 16061096.
    Citations: 41     Fields:    Translation:Humans
  114. Thorne JE, Jabs DA, Peters GB, Hair D, Dunn JP, Kempen JH. Birdshot retinochoroidopathy: ocular complications and visual impairment. Am J Ophthalmol. 2005 Jul; 140(1):45-51. PMID: 16038650.
    Citations: 20     Fields:    Translation:Humans
  115. Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis. Am J Ophthalmol. 2005 Jun; 139(6):1028-34. PMID: 15953432.
    Citations: 6     Fields:    Translation:HumansCells
  116. Jabs DA, Holbrook JT, Van Natta ML, Clark R, Jacobson MA, Kempen JH, Murphy RL. Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology. 2005 May; 112(5):771-9. PMID: 15878056.
    Citations: 26     Fields:    Translation:Humans
  117. Kuo IC, Kempen JH, Dunn JP, Vogelsang G, Jabs DA. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection. Am J Ophthalmol. 2004 Sep; 138(3):338-46. PMID: 15364214.
    Citations: 10     Fields:    Translation:Humans
  118. Congdon N, O'Colmain B, Klaver CC, Klein R, Muñoz B, Friedman DS, Kempen J, Taylor HR, Mitchell P. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004 Apr; 122(4):477-85. PMID: 15078664.
    Citations: 606     Fields:    Translation:Humans
  119. Roy MS, Klein R, O'Colmain BJ, Klein BE, Moss SE, Kempen JH. The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. Arch Ophthalmol. 2004 Apr; 122(4):546-51. PMID: 15078673.
    Citations: 32     Fields:    Translation:Humans
  120. Friedman DS, Wolfs RC, O'Colmain BJ, Klein BE, Taylor HR, West S, Leske MC, Mitchell P, Congdon N, Kempen J. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004 Apr; 122(4):532-8. PMID: 15078671.
    Citations: 221     Fields:    Translation:Humans
  121. Congdon N, Vingerling JR, Klein BE, West S, Friedman DS, Kempen J, O'Colmain B, Wu SY, Taylor HR. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol. 2004 Apr; 122(4):487-94. PMID: 15078665.
    Citations: 133     Fields:    Translation:Humans
  122. Kempen JH, O'Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, Taylor HR, Hamman RF. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004 Apr; 122(4):552-63. PMID: 15078674.
    Citations:    
  123. Kempen JH, Mitchell P, Lee KE, Tielsch JM, Broman AT, Taylor HR, Ikram MK, Congdon NG, O'Colmain BJ. The prevalence of refractive errors among adults in the United States, Western Europe, and Australia. Arch Ophthalmol. 2004 Apr; 122(4):495-505. PMID: 15078666.
    Citations:    
  124. Hubbard LD, Ricks MO, Martin BK, Bressler NM, Kempen JH, Dunn JP, Jabs DA. Comparability of two fundus photograph reading centers in grading cytomegalovirus retinitis progression. Am J Ophthalmol. 2004 Mar; 137(3):426-34. PMID: 15013864.
    Citations: 3     Fields:    Translation:Humans
  125. Tanna AP, Kempen JH, Dunn JP, Haller JA, Jabs DA. Incidence and management of cataract after retinal detachment repair with silicone oil in immune compromised patients with cytomegalovirus retinitis. Am J Ophthalmol. 2003 Dec; 136(6):1009-15. PMID: 14644210.
    Citations: 4     Fields:    Translation:Humans
  126. Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia J. Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome. Clin Infect Dis. 2003 Nov 15; 37(10):1365-73. PMID: 14583871.
    Citations: 19     Fields:    Translation:Humans
  127. Kempen JH, Martin BK, Wu AW, Barron B, Thorne JE, Jabs DA. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology. 2003 May; 110(5):987-95. PMID: 12750102.
    Citations: 6     Fields:    Translation:HumansCells
  128. Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia JA. Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol. 2003 Apr; 121(4):466-76. PMID: 12695243.
    Citations: 13     Fields:    Translation:Humans
  129. Hylton C, Congdon N, Friedman D, Kempen J, Quigley H, Bass E, Jampel H. Cataract after glaucoma filtration surgery. Am J Ophthalmol. 2003 Feb; 135(2):231-2. PMID: 12566033.
    Citations: 11     Fields:    Translation:Humans
  130. Jabs DA, Martin BK, Forman MS, Hubbard L, Dunn JP, Kempen JH, Davis JL, Weinberg DV. Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis. Am J Ophthalmol. 2003 Jan; 135(1):26-34. PMID: 12504693.
    Citations: 7     Fields:    Translation:HumansCellsCTClinical Trials
  131. Jampel HD, Friedman DS, Lubomski LH, Kempen JH, Quigley H, Congdon N, Levkovitch-Verbin H, Robinson KA, Bass EB. Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: An evidence-based review. Ophthalmology. 2002 Dec; 109(12):2215-24; quiz 2225, 2231. PMID: 12466161.
    Citations: 22     Fields:    Translation:Humans
  132. Friedman DS, Jampel HD, Lubomski LH, Kempen JH, Quigley H, Congdon N, Levkovitch-Verbin H, Robinson KA, Bass EB. Surgical strategies for coexisting glaucoma and cataract: an evidence-based update. Ophthalmology. 2002 Oct; 109(10):1902-13. PMID: 12359612.
    Citations: 36     Fields:    Translation:Humans
  133. Jampel HD, Friedman DS, Lubomski LH, Kempen JH, Quigley H, Congdon N, Levkovitch-Verbin H, Robinson KA, Bass EB. Methodologic rigor of clinical trials on surgical management of eyes with coexisting cataract and glaucoma. Ophthalmology. 2002 Oct; 109(10):1892-901. PMID: 12359611.
    Citations:    Fields:    Translation:Humans
  134. Jabs DA, Gilpin AM, Min YI, Erice A, Kempen JH, Quinn TC. HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial. AIDS. 2002 Apr 12; 16(6):877-87. PMID: 11919489.
    Citations: 7     Fields:    Translation:HumansCellsCTClinical Trials
  135. Jabs DA, Van Natta ML, Kempen JH, Reed Pavan P, Lim JI, Murphy RL, Hubbard LD. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol. 2002 Jan; 133(1):48-61. PMID: 11755839.
    Citations: 33     Fields:    Translation:HumansCells
  136. Friedman DS, Bass EB, Lubomski LH, Fleisher LA, Kempen JH, Magaziner J, Sprintz M, Robinson K, Schein OD. Synthesis of the literature on the effectiveness of regional anesthesia for cataract surgery. Ophthalmology. 2001 Mar; 108(3):519-29. PMID: 11237906.
    Citations:    
  137. Friedman DS, Bass EB, Lubomski LH, Fleisher LA, Kempen JH, Magaziner J, Sprintz M, Robinson K, Schein OD. The methodologic quality of clinical trials on regional anesthesia for cataract surgery. Ophthalmology. 2001 Mar; 108(3):530-41. PMID: 11237907.
    Citations:    
  138. Kempen JH, Jabs DA, Dunn JP, West SK, Tonascia J. Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome. Arch Ophthalmol. 2001 Jan; 119(1):33-40. PMID: 11146724.
    Citations:    
  139. Kempen JH, Frick KD, Jabs DA. Incremental cost effectiveness of prophylaxis for cytomegalovirus disease in patients with AIDS. Pharmacoeconomics. 2001; 19(12):1199-208. PMID: 11772155.
    Citations:    
  140. Nguyen QD, Kempen JH, Bolton SG, Dunn JP, Jabs DA. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol. 2000 May; 129(5):634-9. PMID: 10844056.
    Citations:    
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kempen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (332)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.